These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38645430)

  • 1. Editorial: The role of GPCRs in obesity.
    Zhang C; Wang Y; Kimura T; Al-Mrabeh AH
    Front Endocrinol (Lausanne); 2024; 15():1404969. PubMed ID: 38645430
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic Functions of G Protein-Coupled Receptors and β-Arrestin-Mediated Signaling Pathways in the Pathophysiology of Type 2 Diabetes and Obesity.
    Oliveira de Souza C; Sun X; Oh D
    Front Endocrinol (Lausanne); 2021; 12():715877. PubMed ID: 34497585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G Protein-Coupled Receptors Targeting Insulin Resistance, Obesity, and Type 2 Diabetes Mellitus.
    Riddy DM; Delerive P; Summers RJ; Sexton PM; Langmead CJ
    Pharmacol Rev; 2018 Jan; 70(1):39-67. PubMed ID: 29233848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiling of G-Protein Coupled Receptors in Adipose Tissue and Differentiating Adipocytes Offers a Translational Resource for Obesity/Metabolic Research.
    Al Mahri S; Okla M; Rashid M; Malik SS; Iqbal J; Al Ibrahim M; Dairi G; Mahmood A; Muthurangan M; Yaqinuddin A; Mohammad S
    Cells; 2023 Jan; 12(3):. PubMed ID: 36766718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity-induced changes in human islet G protein-coupled receptor expression: Implications for metabolic regulation.
    Atanes P; Ashik T; Persaud SJ
    Pharmacol Ther; 2021 Dec; 228():107928. PubMed ID: 34174278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in mouse visceral adipose tissue mRNA expression of islet G-protein-coupled receptor ligands in obesity.
    Ashik T; Lee V; Atanes P; Persaud SJ
    Diabet Med; 2022 Dec; 39(12):e14978. PubMed ID: 36245259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central G-Protein Coupled Receptors (GPCR)s as molecular targets for the treatment of obesity: assets, liabilities and development status.
    Miller KJ; Murphy BJ; Pelleymounter MA
    Curr Drug Targets CNS Neurol Disord; 2004 Oct; 3(5):357-77. PubMed ID: 15544445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Designer G Protein-Coupled Receptors to Dissect Metabolic Pathways.
    Wess J
    Trends Endocrinol Metab; 2016 Sep; 27(9):600-603. PubMed ID: 27381463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of changes in human islet G protein-coupled receptor mRNA expression in obesity.
    Lyu Z; Zhao M; Atanes P; Persaud SJ
    Diabet Med; 2022 Dec; 39(12):e14974. PubMed ID: 36260369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Ancient Link between G-Protein-Coupled Receptors and C-Terminal Phospholipid Kinase Domains.
    van den Hoogen DJ; Meijer HJG; Seidl MF; Govers F
    mBio; 2018 Jan; 9(1):. PubMed ID: 29362235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolite-sensing GPCRs controlling interactions between adipose tissue and inflammation.
    Duncan EM; Vita L; Dibnah B; Hudson BD
    Front Endocrinol (Lausanne); 2023; 14():1197102. PubMed ID: 37484963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory roles of G-protein coupled receptors in adipose tissue metabolism and their therapeutic potential.
    Im H; Park JH; Im S; Han J; Kim K; Lee YH
    Arch Pharm Res; 2021 Feb; 44(2):133-145. PubMed ID: 33550564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An mRNA atlas of G protein-coupled receptor expression during primary human monocyte/macrophage differentiation and lipopolysaccharide-mediated activation identifies targetable candidate regulators of inflammation.
    Hohenhaus DM; Schaale K; Le Cao KA; Seow V; Iyer A; Fairlie DP; Sweet MJ
    Immunobiology; 2013 Nov; 218(11):1345-53. PubMed ID: 23948647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orphan G-protein-coupled receptors : strategies for identifying ligands and potential for use in eating disorders.
    Harrold JA; Halford JC
    Drugs R D; 2007; 8(5):287-99. PubMed ID: 17767394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G protein-coupled receptors as regulators of energy homeostasis.
    Tao YX; Yuan ZH; Xie J
    Prog Mol Biol Transl Sci; 2013; 114():1-43. PubMed ID: 23317781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolite G-Protein Coupled Receptors in Cardio-Metabolic Diseases.
    Strassheim D; Sullivan T; Irwin DC; Gerasimovskaya E; Lahm T; Klemm DJ; Dempsey EC; Stenmark KR; Karoor V
    Cells; 2021 Nov; 10(12):. PubMed ID: 34943862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The G protein G
    Bondar A; Lazar J
    J Biol Chem; 2017 Jun; 292(23):9690-9698. PubMed ID: 28438833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G protein-coupled receptors function as cell membrane receptors for the steroid hormone 20-hydroxyecdysone.
    Zhao XF
    Cell Commun Signal; 2020 Sep; 18(1):146. PubMed ID: 32907599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G Protein-Coupled Receptors (GPCRs)-Mediated Calcium Signaling in Ovarian Cancer: Focus on GPCRs activated by Neurotransmitters and Inflammation-Associated Molecules.
    Predescu DV; Crețoiu SM; Crețoiu D; Pavelescu LA; Suciu N; Radu BM; Voinea SC
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31703453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G protein-coupled receptors as therapeutic targets for obesity and type 2 diabetes.
    Bjenning C; Al-Shamma H; Thomsen W; Leonard J; Behan D
    Curr Opin Investig Drugs; 2004 Oct; 5(10):1051-62. PubMed ID: 15535426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.